Anthony Cheung

Founder at ENGENE THERAPEUTICS INC.

Net worth: 184 143 $ as of 2026-07-30

55 year

25 connections

Consumer Services

Health Technology

Commercial Services

Profile

Anthony T.
Cheung is the founder of enGene Therapeutics, Inc., founded in 2023.
Dr. Cheung holds the title of Chief Scientific Officer at enGene Therapeutics, Inc. Dr. Cheung is also the founder of enGene, Inc...
Dr. Cheung completed undergraduate education at the University of British Columbia.
Dr. Cheung earned a doctorate from Tulane University School of Medicine.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
ENGENE THERAPEUTICS INC. 0.15%	2026-06-15	102,873 ( 0.15% )	184 143 $	2026-07-30

Anthony Cheung active positions

Companies	Position	Start
ENGENE THERAPEUTICS INC.	Founder	2023-04-23

All active positions of Anthony Cheung

Former positions of Anthony Cheung

Companies	Position	End
enGene, Inc. enGene, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company, which develops non-viral gene therapies	Chief Executive Officer	2018-07-15

See the detail of Anthony Cheung's experience

Training of Anthony Cheung

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Anthony Cheung's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
enGene, Inc. enGene, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company, which develops non-viral gene therapies	Health Technology
University of British Columbia University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Tulane University School of Medicine Tulane University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
enGene Holdings, Inc. enGene Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that develops, manufactures and sells non-viral genetic medicines	Commercial Services